Product
Spikevax bivalent
1 clinical trial
1 indication
Indication
CancerClinical trial
COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2Status: Terminated, Estimated PCD: 2024-01-08
1 clinical trial
1 indication